OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Jason Aldred, Eric Freire‐Alvarez, А. В. Амелин, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1937-1958
Open Access | Times Cited: 38

Showing 26-50 of 38 citing articles:

Potential Psychosis Induced by Sustained High Plasma Levodopa Concentration via Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson’s Disease: A Case Report
Toshiki Tezuka, Tomonori Nukariya, Yuta Kizuka, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 4, pp. 453-455
Open Access | Times Cited: 1

Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s Disease (aPD): demonstration of savings from a societal perspective in the UK
К. Ray Chaudhuri, Lars Bergmann, Jonathan Belsey, et al.
Journal of Medical Economics (2024), pp. 1-18
Open Access | Times Cited: 1

Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations
Alexander Storch, Alexander Bremer, Florin Gandor, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1451-1468
Open Access | Times Cited: 1

Algorithm for managing infusion site adverse events caused by subcutaneous foslevodopa/foscarbidopa and other device-aided therapies for advanced Parkinson’s Disease
Pedro Mendes‐Bastos, Rita Basílio Simões
Parkinsonism & Related Disorders (2024), pp. 107185-107185
Closed Access | Times Cited: 1

A patient with Parkinson’s disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/foscarbidopa infusion
Hirotaka Sakuramoto, Hiroaki Fujita, Keitaro Ogaki, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100292-100292
Open Access | Times Cited: 1

Tips and tricks in tremor treatment
Franziska Hopfner, Carsten Buhmann, Joseph Claßen, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 10, pp. 1229-1246
Open Access

Patient selection for device aided therapies
Ştefania Diaconu, Larisa Ungureanu, Iulia Murăşan, et al.
International review of movement disorders (2024)
Closed Access

Risk of fall with device-based advanced treatments in Parkinson’s disease: a systematic review and network meta-analysis
Rajasumi Rajalingam, Gianluca U. Sorrento, Alfonso Fasano
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334521
Closed Access

Utilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study
Martin Südmeyer, David J. Pedrosa, Frank Siebecker, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 630-630
Open Access

Monotherapy with infusion therapies – useful or not?
Petra Bago Rožanković, Anders Johansson, Klivényi Péter, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 11, pp. 1341-1348
Closed Access

Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics
Hiroshi Kataoka, Kazuma Sugie
Clinical Neurology and Neurosurgery (2024) Vol. 245, pp. 108493-108493
Closed Access

Subcutaneous foslevodopa/foscarbidopa: A novel 24 h delivery option for levodopa
Karolina Popławska-Domaszewicz, К. Ray Chaudhuri
International review of movement disorders (2024), pp. 63-79
Closed Access

Previous Page - Page 2

Scroll to top